A detailed history of Tejara Capital LTD transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 650,265 shares of SCPH stock, worth $2.2 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
650,265
Previous 704,742 7.73%
Holding current value
$2.2 Million
Previous $3.07 Billion 3.28%
% of portfolio
1.41%
Previous 1.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.12 - $5.51 $224,445 - $300,168
-54,477 Reduced 7.73%
650,265 $2.97 Billion
Q2 2024

Aug 13, 2024

BUY
$3.51 - $5.21 $23,011 - $34,156
6,556 Added 0.94%
704,742 $3.07 Billion
Q1 2024

May 14, 2024

SELL
$4.86 - $6.39 $289,583 - $380,748
-59,585 Reduced 7.86%
698,186 $3.5 Billion
Q4 2023

Feb 12, 2024

BUY
$4.7 - $6.63 $3.08 Million - $4.35 Million
656,357 Added 647.21%
757,771 $4.75 Billion
Q3 2023

Nov 13, 2023

BUY
$7.0 - $9.82 $709,898 - $995,885
101,414 New
101,414 $722 Million

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $92.6M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.